PT855913E - IRON-DEXTRAN FORMULATIONS - Google Patents
IRON-DEXTRAN FORMULATIONSInfo
- Publication number
- PT855913E PT855913E PT96930686T PT96930686T PT855913E PT 855913 E PT855913 E PT 855913E PT 96930686 T PT96930686 T PT 96930686T PT 96930686 T PT96930686 T PT 96930686T PT 855913 E PT855913 E PT 855913E
- Authority
- PT
- Portugal
- Prior art keywords
- iron
- dextran formulations
- dextran
- formulations
- daltons
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Abstract
Ferric oxyhydroxide-dextran compositions for treating iron deficiency having ellipsoidal particles with a preferred molecular weight range of about 250,000 to 300,000 daltons.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/536,984 US5624668A (en) | 1995-09-29 | 1995-09-29 | Iron dextran formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
PT855913E true PT855913E (en) | 2002-11-29 |
Family
ID=24140716
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT96930686T PT855913E (en) | 1995-09-29 | 1996-08-29 | IRON-DEXTRAN FORMULATIONS |
Country Status (11)
Country | Link |
---|---|
US (1) | US5624668A (en) |
EP (1) | EP0855913B1 (en) |
JP (1) | JP3471363B2 (en) |
AT (1) | ATE218875T1 (en) |
AU (1) | AU702691B2 (en) |
CA (1) | CA2184551C (en) |
DE (1) | DE69621813T2 (en) |
DK (1) | DK0855913T3 (en) |
ES (1) | ES2179207T3 (en) |
PT (1) | PT855913E (en) |
WO (1) | WO1997011711A1 (en) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306384B1 (en) * | 1996-10-01 | 2001-10-23 | E-L Management Corp. | Skin battery cosmetic composition |
DK172860B1 (en) * | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron man |
US6610206B1 (en) | 1998-10-20 | 2003-08-26 | Advanced Renal Technologies | Buffered compositions for dialysis |
US7670491B2 (en) * | 1998-10-20 | 2010-03-02 | Advanced Renal Technologies | Buffered compositions for dialysis |
DK173138B1 (en) | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Process for Preparing an Iron Dextran Compound, Iron Dextran Compound Prepared by the Process, Pharmaceutical |
EP2052751A3 (en) * | 1999-09-22 | 2009-06-03 | Advanced Renal Technologies | Use of high citrate dialysate |
US6929954B2 (en) * | 2000-11-02 | 2005-08-16 | Chromaceutical Advanced Technologies, Inc. | Method for producing purified hematinic iron-saccharidic complex and product produced |
EP1719496A3 (en) * | 2000-11-02 | 2007-05-16 | Chromaceutical Advanced Technologies, Inc. | Method for producing purified hematinic iron-saccharidic complex and product produced |
EP2275075A3 (en) | 2000-11-02 | 2011-08-10 | Chromaceutical Advanced Technologies, Inc. | Method of measuring an iron-saccharidic complex |
US6825032B2 (en) * | 2001-05-14 | 2004-11-30 | Sigma-Aldrich Co. | High capacity assay platforms |
US7169359B2 (en) * | 2002-08-26 | 2007-01-30 | Luitpold Pharmaceuticals, Inc. | Bioequivalence test for iron-containing formulations |
US6911342B2 (en) * | 2002-08-26 | 2005-06-28 | Luitpold Pharmaceuticals, Inc. | Bioequivalence test for iron-containing formulations |
DE10249552A1 (en) * | 2002-10-23 | 2004-05-13 | Vifor (International) Ag | Water-soluble iron-carbohydrate complexes, their preparation and medicaments containing them |
US7390472B1 (en) * | 2002-10-29 | 2008-06-24 | Nei Corp. | Method of making nanostructured lithium iron phosphate—based powders with an olivine type structure |
US20040161852A1 (en) * | 2003-02-14 | 2004-08-19 | Anderson Christopher G. | Method of assaying an Fe-Sugar complex |
US20060116349A1 (en) * | 2003-03-14 | 2006-06-01 | Luitpold Pharmaceuticals, Inc. | Methods and compositions for administration of iron for the treatment of restless leg syndrome |
US7964568B2 (en) * | 2003-05-30 | 2011-06-21 | Chromaceutical Advanced Technologies, Inc. | Synthesis of high molecular weight iron-saccharidic complexes |
US7449196B2 (en) * | 2004-07-09 | 2008-11-11 | Robert Sabin | Anti tumor compositions and methods of use |
AU2005271897B2 (en) | 2004-07-09 | 2008-06-19 | Robert Sabin | Compositions and methods of use for treatment of mammalian diseases |
AU2016205002C1 (en) * | 2006-01-06 | 2020-09-24 | Vifor (International) Ag | Methods and compositions for administration of iron |
KR20180077337A (en) * | 2006-01-06 | 2018-07-06 | 루이트폴드 파머수티컬스, 인코퍼레이티드 | Methods and compositions for administration of iron |
AU2013206429B2 (en) * | 2006-01-06 | 2016-04-28 | Vifor (International) Ag | Methods and compositions for administration of iron |
US20080081051A1 (en) * | 2006-09-28 | 2008-04-03 | Robert Sabin | Method of manufacturing anti-tumor and anti-viral compositions |
US20080132465A1 (en) * | 2006-12-05 | 2008-06-05 | Vincent Windisch | Apparatus and method for isolating iron components from serum |
CN105380936A (en) * | 2006-12-12 | 2016-03-09 | 味之素株式会社 | Iron metabolism-improving agent |
TWI592159B (en) | 2007-11-16 | 2017-07-21 | 威佛(國際)股份有限公司 | Pharmaceutical compositions |
SI3156075T1 (en) | 2009-03-25 | 2021-03-31 | Pharmacosmos Holding A/S | An oligosaccharide and a process for preparation thereof |
US8058076B2 (en) * | 2009-03-31 | 2011-11-15 | Astron Research Limited | In-vitro method for testing bioequivalence of iron-sucrose formulation |
PT104879B (en) * | 2009-12-10 | 2012-10-17 | Univ Do Minho | DEXTRINO HYDROGEL FOR BIOMEDICAL APPLICATIONS |
US9566303B2 (en) | 2011-10-13 | 2017-02-14 | Vidasym, Inc. | Iron-fiber composition, preparation and uses thereof |
CN103044571A (en) * | 2011-10-13 | 2013-04-17 | 天津中敖生物科技有限公司 | Iron dextran bulk drug and preparation method thereof |
CA2901018C (en) * | 2013-03-08 | 2022-05-03 | Vidasym, Inc. | Metal ion-functional fiber component complex compositions, preparation and uses thereof |
US9370202B2 (en) | 2013-03-15 | 2016-06-21 | LG Bionano, LLC | Encapsulated metal ion nanoclusters |
WO2018198135A1 (en) * | 2017-04-26 | 2018-11-01 | Mylan Laboratories Ltd. | Improved process for the preparation of iron complex |
SG11202005207PA (en) * | 2017-12-07 | 2020-07-29 | Commw Scient Ind Res Org | Sugar reduced products and method of producing thereof |
FI3930686T3 (en) | 2019-02-28 | 2023-09-01 | Renibus Therapeutics Inc | Novel iron compositions and methods of making and using the same |
CN113567370A (en) * | 2021-07-23 | 2021-10-29 | 广西南宁市桃源兽药厂 | Method for detecting content of sugar anhydride in iron dextran injection |
CN116712455B (en) * | 2023-06-30 | 2024-04-05 | 重庆汉佩生物科技有限公司 | Composition of florfenicol and iron glucoheptonate |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
USRE24642E (en) * | 1959-04-28 | Therapeutic preparations of iron | ||
US2820740A (en) * | 1953-02-27 | 1958-01-21 | Benger Lab Ltd | Therapeutic preparations of iron |
US2885393A (en) * | 1956-02-24 | 1959-05-05 | R K Laros Company | Dextran-iron complex and process for making same |
US3697502A (en) * | 1969-11-03 | 1972-10-10 | Christensen Henry M | Method of making iron dextran-preparations |
US3686397A (en) * | 1970-05-18 | 1972-08-22 | Mueller Arthur | Parenteral iron preparations |
US3908004A (en) * | 1970-05-20 | 1975-09-23 | C L Basingstoke Limited | Process for making injectable iron compositions for treating iron-deficiency anemia |
JPS5913521B2 (en) * | 1975-06-19 | 1984-03-30 | メイトウサンギヨウ カブシキガイシヤ | Method for producing magnetic iron oxide/dextran complex |
US4180567A (en) * | 1977-09-02 | 1979-12-25 | Pharmachem Corporation | Iron preparations and methods of making and administering the same |
DE3026868C2 (en) * | 1980-07-16 | 1986-03-13 | Laboratorien Hausmann AG, St. Gallen | Process for the preparation of iron (III) hydroxide-dextran complexes and pharmaceutical sterile aqueous solution containing them |
US4454773A (en) * | 1981-11-06 | 1984-06-19 | Texaco Inc. | Time interval automatic well multi-phase fluid sampler |
US4452773A (en) * | 1982-04-05 | 1984-06-05 | Canadian Patents And Development Limited | Magnetic iron-dextran microspheres |
JPS58199018A (en) * | 1982-05-18 | 1983-11-19 | Nippon Denso Co Ltd | Purifying device equipped with electrically heating means for fine particle contained in waste gas |
US4659697A (en) * | 1983-05-20 | 1987-04-21 | Kentaro Tanaka | Antianaemic composition and a process for producing the same |
US4788281A (en) * | 1984-01-04 | 1988-11-29 | Tosoni Anthony L | Dextran hexonic acid derivative, ferric hydroxide complex and method manufacture thereof |
DE3422249A1 (en) * | 1984-06-15 | 1985-12-19 | Pfeifer & Langen, 5000 Köln | WATER-SOLUBLE IRON DEXTRANE AND METHOD FOR THE PRODUCTION THEREOF |
US5102652A (en) * | 1986-07-03 | 1992-04-07 | Advanced Magnetics Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
US5248492A (en) * | 1986-07-03 | 1993-09-28 | Advanced Magnetics, Inc. | Low molecular weight carbohydrates as additives to stabilize metal oxide compositions |
US5336506A (en) * | 1986-07-03 | 1994-08-09 | Advanced Magnetics Inc. | Targeting of therapeutic agents using polysaccharides |
US5118513A (en) * | 1987-07-02 | 1992-06-02 | The Procter & Gamble Company | Method for enhancing bioavailability of iron-calcium mineral supplements |
US5354350A (en) * | 1993-12-14 | 1994-10-11 | The Vigoro Corporation | Citrate soluble slow release iron humate |
-
1995
- 1995-09-29 US US08/536,984 patent/US5624668A/en not_active Expired - Lifetime
-
1996
- 1996-08-29 WO PCT/US1996/014153 patent/WO1997011711A1/en active IP Right Grant
- 1996-08-29 ES ES96930686T patent/ES2179207T3/en not_active Expired - Lifetime
- 1996-08-29 DE DE69621813T patent/DE69621813T2/en not_active Expired - Lifetime
- 1996-08-29 AT AT96930686T patent/ATE218875T1/en active
- 1996-08-29 EP EP96930686A patent/EP0855913B1/en not_active Expired - Lifetime
- 1996-08-29 PT PT96930686T patent/PT855913E/en unknown
- 1996-08-29 AU AU69647/96A patent/AU702691B2/en not_active Ceased
- 1996-08-29 JP JP51343997A patent/JP3471363B2/en not_active Expired - Lifetime
- 1996-08-29 DK DK96930686T patent/DK0855913T3/en active
- 1996-08-30 CA CA002184551A patent/CA2184551C/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2184551A1 (en) | 1997-03-30 |
EP0855913A1 (en) | 1998-08-05 |
CA2184551C (en) | 2001-11-27 |
JP3471363B2 (en) | 2003-12-02 |
JPH11512706A (en) | 1999-11-02 |
DE69621813D1 (en) | 2002-07-18 |
US5624668A (en) | 1997-04-29 |
EP0855913B1 (en) | 2002-06-12 |
WO1997011711A1 (en) | 1997-04-03 |
DE69621813T2 (en) | 2003-01-23 |
ES2179207T3 (en) | 2003-01-16 |
DK0855913T3 (en) | 2002-10-07 |
AU6964796A (en) | 1997-04-17 |
EP0855913A4 (en) | 1999-01-20 |
AU702691B2 (en) | 1999-03-04 |
ATE218875T1 (en) | 2002-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT855913E (en) | IRON-DEXTRAN FORMULATIONS | |
PT762888E (en) | IMPROVEMENTS OF COPOLYMER-1 IN COPOLYMER COMPOSITIONS | |
TW368504B (en) | Modified arginine deiminase | |
UA39158C2 (en) | derivatives of N4-oxycarbonyl- 5'-deoxy-5-fluorocytidine and pharmaceutical preparation based thereon | |
ES2124479T3 (en) | BIOCIDAL COMPOSITIONS. | |
CY2431B1 (en) | Novel phenanthridines substituted in the 6 position. | |
MX9804588A (en) | Use of halogen bleach-comprising compositions for improved mildness to the skin. | |
MY115211A (en) | Novel amino acid derivatives, their preparation and use | |
DE69633178D1 (en) | Iron compounds, compositions, methods of preparation and uses thereof | |
TW349000B (en) | Fungicidal two-component composition based on R-metalaxyl and usage thereof | |
BR9609114A (en) | Insecticidal composition of diatomaceous earth | |
EA199700032A1 (en) | DISINFECTING COMPOSITION "VELTOLEN" | |
DE69614552T2 (en) | MODIFIED ALPHA-D-GLCP- (1,2) -ALPHA-D-Glcp- (1,3) -ALPHA-D-Glcp ANALOGS | |
FI973499A0 (en) | Antitumor benzothiopyranoindazoles | |
FR2729529B1 (en) | PLUG-IN INSTALLATION OF ELONGATED PIECES | |
BR9609724A (en) | Cleaning composition | |
UA30250A (en) | Anti-oxidant remedy |